The Angelman Syndrome Foundation (ASF) and the Foundation for Angelman Syndrome Therapeutics (FAST) are hosting the inaugural Angelman Syndrome (AS) Congressional Advocacy Day in Washington, D.C.
The risk of stroke tied to sleep apnea may vary for Black people and white people, according to a study published in the March 6, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Dementia may be three times more common among people with essential tremor, a movement disorder that causes involuntary shaking, than the general population, according to research released today, March 6, 2024. The study will be presented at the American Academy of Neurology’s 76th Annual Meeting taking place April 13–18, 2024, in person in Denver and online.
Fragile X syndrome is one of the most commonly inherited forms of autism and intellectual disability, and no treatment currently exists. But a team of University of Illinois researchers has discovered a novel receptor function that may be used in a therapeutic approach to treatment.
People who have headaches after experiencing concussions may also be more likely to have higher levels of iron in areas of the brain, which is a sign of injury to brain cells, according to a preliminary study released today, March 5, 2024, that will be presented at the American Academy of Neurology’s 76th Annual Meeting taking place April 13–18, 2024, in person in Denver and online.
In the mid-1990s, Dr. Edward (Ted) Reynolds, then president of ILAE, recognized that epilepsy required global solutions. His ideas blossomed into the Global Campaign Against Epilepsy and established partnerships between ILAE, the World Health Organization, and the International Bureau for Epilepsy.
New Cleveland Clinic-led research points to sildenafil (Viagra) as a potential treatment for Alzheimer’s disease. The study provides evidence from computational models, insurance claims data and observations from brain cells in Alzheimer’s patients.
Sildenafil is the main component of drugs used to treat erectile dysfunction (Viagra) and pulmonary arterial hypertension (Revatio).
Certain medications for multiple sclerosis (MS) called monoclonal antibodies, taken while breastfeeding, may not affect the development of a child during the first three years of life, according to a preliminary study released today, March 4, 2024. The study will be presented at the American Academy of Neurology’s 76th Annual Meeting taking place April 13–18, 2024, in person in Denver and online. The study examined four monoclonal antibodies for MS: natalizumab, ocrelizumab, rituximab and ofatumumab.
The International Commission on Non-Ionizing Radiation Protection (ICNIRP) has identified a lack of consensus among public health officials about whether SWL from artificial sources disrupts circadian rhythm, and if so, whether SWL-disrupted circadian rhythm is associated with adverse health outcomes.
A special session at the American Epilepsy Society meeting in December 2023 reviewed progress on the Intersectoral Global Action Plan on Epilepsy and other Neurological Disorders (IGAP) and discussed strategies for moving forward.
Children’s Hospital Los Angeles (CHLA) neurologist Shafali Spurling Jeste, MD, has been named the 2024 recipient of the prestigious Martha Bridge Denckla Award from the Child Neurology Society. This award—named after a physician who pioneered the field of developmental cognitive neurology—honors physician-scientists of international standing who conduct research and clinical care focused on neurodevelopmental and neurobehavioral disorders.
In a new study, published online today in Scientific Reports, researchers found differences in how people with ICD process the consequences of their actions compared to those without ICD, both on and off medication.
People who experience sleep apnea may be more likely to also have memory or thinking problems, according to a preliminary study released today, March 3, 2024, that will be presented at the American Academy of Neurology’s 76th Annual Meeting taking place April 13–18, 2024, in person in Denver and online. The study shows a positive association but did not determine whether sleep apnea causes cognitive decline.
A University of Delaware lab is now pioneering the use of video games – specifically Nintendo Switch's Ring Fit – as an intervention to enhance movement and motor skills for children with autism. The research further demonstrates the positive impact of exercise-based games on cognition and social interactions.
Saint Louis University associate professor of health management and policy in the College for Public Health and Social Justice, SangNam Ahn, Ph.D., recently published a paper in Journal of Clinical Psychology that examines the relationship between childhood adversity, and psychiatric decline as well as adult adversity and psychiatric and cognitive decline.
UCLA Health researchers have discovered a group of specialized support cells in the brain that can regulate behaviors associated with human neuropsychiatric disorders.
Johns Hopkins Medicine neuroscientists say they have found a new function for the SYNGAP1 gene, a DNA sequence that controls memory and learning in mammals, including mice and humans.
Klaus Hahn, PhD, the Ronald G. Thurman Distinguished Professor of Pharmacology at the UNC School of Medicine, will co-lead this Chan Zuckerberg Initiative project with colleagues at Duke University and North Carolina State University.
UT Southwestern Medical Center researchers have developed an artificial intelligence (AI) method that writes its own algorithms and may one day operate as an "automated scientis" to extract the meaning behind complex datasets.
Supported by a $2 million R01 grant from the National Institutes of Health, the Auerbach Lab at the Beckman Institute for Advanced Science and Technology will examine how different genes associated with autism spectrum disorders may similarly impact our brain’s neurons, resulting in heightened sensitivity to sounds.
Individuals with Williams syndrome have a gregarious “cocktail party” personality, while those with the opposite genetic alteration, in contrast, tend to have autistic traits and are prone to struggle socially. Research from UC San Diego sheds new light on the gene responsible.
For people with drug-resistant epilepsy, having a dog companion trained in detecting seizures and other epilepsy-related tasks may reduce the amount of seizures they have, according to new research published in the February 28, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. For the study, researchers looked at adults with severe epilepsy who have been unable to find effective treatment to reduce seizures.
For children and teens, irregular meals such as skipped breakfasts are linked to an increased risk of frequent headaches, according to a new study published in the February 28, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study also found that for those ages 12 to 17, substance use and exposure, specifically electronic cigarettes (e-cigarettes), were associated with frequent headaches.
For people with stroke, social factors such as education, neighborhood and employment may be linked to whether they receive treatment with clot-busting drugs, according to a preliminary study released today, February 28, 2024, that will be presented at the American Academy of Neurology’s 76th Annual Meeting taking place April 13–18, 2024, in person in Denver and online. The study looked at people with ischemic stroke, which is caused by a blockage of blood flow to the brain and is the most common type of stroke.
New research at the UNC School of Medicine provides new insights into the brain processes that underlie cocaine addiction. The findings are crucial for developing new therapeutics and identifying an imaging marker for cocaine use disorders.
Mitzi Gonzales, PhD, a board-certified neuropsychologist, has joined Cedars-Sinai as director of Translational Research in the Jona Goldrich Center for Alzheimer’s and Memory Disorders in the Department of Neurology at Cedars-Sinai.
Researchers at Washington University School of Medicine in St. Louis have found that brain cell activity during sleep is responsible for propelling fluid into, through and out of the brain, cleaning it of debris.
Researchers at the Icahn School of Medicine at Mount Sinai and others have harnessed the power of machine learning to identify key predictors of mortality in dementia patients. The study, published in the February 28 online issue of Communications Medicine, addresses critical challenges in dementia care by pinpointing patients at high risk of near-term death and uncovers the factors that drive this risk. Unlike previous studies that focused on diagnosing dementia, this research delves into predicting patient prognosis, shedding light on mortality risks and contributing factors in various kinds of dementia.
Physician scientists at The Ohio State University Wexner Medical Center and College of Medicine are studying why multiple sclerosis (MS) worsens as patients grow older. The "Aging with MS Clinic" provides complete care for older adults with MS.
Cannabis products high in the nonintoxicating compound CBD can quell anxiety better than THC-dominant products— and without the potential side effects, new University of Colorado Boulder research suggests.
Bridging precision engineering and precision medicine to create personalized physiology avatars. Pursuing on-demand tissue and organ engineering for human health. Revolutionizing neuroscience by using AI to engineer advanced brain interface systems. Engineering the immune system for health and wellness. Designing and engineering genomes for organism repurposing and genomic perturbations.
Imagine if we could inhale scents that delay the onset of cancer, inflammation, or neurodegenerative disease. Researchers at the University of California, Riverside, are poised to bring this futuristic technology closer to reality.
Two leading multiple sclerosis (MS) experts—Nancy Sicotte, MD, director of Multiple Sclerosis and Neuroimmunology at Cedars-Sinai, and Pascal Sati, PhD, director of the Neuro Imaging Program in the Department of Neurology—are attending the Americas Committee for Treatment and Research in Multiple Sclerosis Forum 2024 Feb. 29-March 2 in West Palm Beach, Florida.
A collaborative team of NIH-funded researchers is developing a way to obtain DNA shed from brain tumors using focused ultrasound. Their first-in-human study could be an important step towards improving the way brain tumors are diagnosed.
Liberating Greatness in Every Neurosurgeon, AtlasGPT Delivers the Most Trusted Decision Support for Brain and Spine Care
Not for public release
This news release is embargoed until 26-Feb-2024 5:00 PM EST
Released to reporters: 20-Feb-2024 2:00 PM EST
A reporter's PressPass is required to
access this story until the embargo expires on 26-Feb-2024 5:00 PM EST
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
The University of Chicago Medicine expanded its neuroscience expertise in China via collaborations with Shanghai Blue Cross Brain Hospital to support improved healthcare delivery, clinical quality and operational efficiency worldwide.
Irvine, Calif., Feb. 26, 2024 — The University of California, Irvine has received a five-year, $4 million grant from the California Institute for Regenerative Medicine to establish a shared resources lab in the Sue & Bill Gross Stem Cell Research Center. The facility will offer essential technologies and training for the development of novel in vitro stem cell-based modeling that will serve researchers across the campus and the state.
JMIR Publications is pleased to announce a new theme issue in JMIR Neurotechnology exploring brain-computer interfaces (BCIs) that represent the transformative convergence of neuroscience, engineering, and technology.
Results of a long-term outcome study found the innovative school social intervention (schoolMAX) and summer social intervention (summerMAX) created by the Institute for Autism Research at Canisius University yielded sustained, comparable, and positive longer-term outcomes for autistic youth (without intellectual disability).
The idea that people make decisions based on social context is not a new one in neural economic games. But now, for the first time, researchers publishing in Nature Human Behavior show the impact of the social context may spring from the dynamic interactions of dopamine and serotonin. Researchers built carbon-fiber electrodes that were implanted in patients receiving Deep Brain Stimulation surgery. The method allows researchers to measure more than one neurotransmitter at a time, revealing a dance that has never been seen before
A new UCLA Health study found Kundalini yoga provided several benefits to cognition and memory for older women at risk of developing Alzheimer’s disease including restoring neural pathways, preventing brain matter decline and reversing aging and inflammation-associated biomarkers – improvements not seen in a group who received standard memory training exercises.
Antidepressant dispensing to adolescents and young adults increased sharply after the COVID-19 pandemic began – particularly among females – a new study finds.
The human brain's adaptability to internal and external changes, known as neural plasticity, forms the foundation for understanding cognitive functions like memory and learning, as well as various neurological disorders.
In recognition of its expertise in treating SCN2A-related neurological disorders, UTHealth Houston has been designated as the first SCN2A Multidisciplinary Center by the FamilieSCN2A Foundation, the largest global advocacy organization for the group of disorders.